The OnPoint AR Spine System, which leverages a unique see-through optical head-mounted display technology, can be readily implemented in hospital settings and is also suitable for ambulatory surgery centres due to its small footprint
The OnPoint AR Spine System approved in the US. (Credit: Bram Van Oost on Unsplash)
OnPoint Surgical, a part of the OnPoint companies, has received the US Food and Drug Administration (FDA) approval for its OnPoint Augmented Reality (AR) Spine System.
The OnPoint AR Spine System leverages a see-through optical head-mounted display technology that overlaps virtual surgical guides and virtual implants onto the surgeon’s visual field.
The system can be readily implemented in hospital settings and is also suitable for ambulatory surgery centres (ASCs) due to its small footprint.
It is available as an open platform, compatible with the implants offered by major manufacturers, and it does not require any change in surgical technique or surgeon practice.
The OnPoint AR Spine System is a cost-effective and highly accurate alternative to current robotic systems, said the medical device company.
OnPoint Surgical chairman and CEO Philipp Lang said: “We are pleased with the 510(k) clearance which will allow the OnPoint Augmented Reality Spine System to be made available for excellence in clinical care nationwide.”
According to the company, OnPoint AR Spine System showed superior performance in cadaver studies, compared to all existing navigation, robotic and augmented reality systems.
Its OnPoint AIm-AR technology is protected by more than 30 patents, granted in the US, China, and the EU terror.
The OnPoint companies, including OnPoint Surgical, OnPoint Medical, OnPoint Knee, OnPoint Hip and OnPoint Sports, are developing AR guidance solutions for surgical procedures.
The companies developed a portfolio of intellectual property related to AR guidance of spinal, neurosurgical, orthopaedic, and arthroscopic procedures, including manual and robotic surgery.
Furthermore, the OnPoint AIm-AR technology platform is being further developed for all spinal, neurosurgical, orthopaedic, arthroscopic, robotic, and other surgical procedures.
Harvard Medical School Brigham and Women’s Hospital neurosurgery vice chair, spinal neurosurgery director, and comprehensive spine surgery co-director Michael Groff said: “I am deeply impressed by its unique accuracy, easy-to-use interface, and the clarity of the information presented.
“I believe that the benefit of this system will be in improving outcomes after surgery, increasing the safety of the surgery, the speed of the surgery, and our confidence that all of our implants are in an optimal position for every patient.”